Lasa Supergenerics Limited, a vertically integrated group spanning the entire animal and human healthcare value chain announced that the company has restarted its mother unit situated at Chiplun, Maharashtra. As company received high court order in its favour In addition to Chiplun unit, the Company has its unit with state of the art manufacturing facilities located at Mahad, Maharashtra with a total installed capacity of 4,300 MT.
Commenting on the recent development, Dr. Omkar Herlekar, Chairman & Managing Director said, “With regard to our business, our order books are full for next few months and we are targeting to meet the time gap of production loss in every possible means with full enthusiasm.”
Market also responding very positive as the stock is up14% in last week though sensex fell 1600 points. Stock seems to be in Bullgrip. Compared to its competitors, Lasa is very good contra value buy. The company currently has a huge order book, and ample of free capacity to execute the Orders and with this court order it has got a nice immunity to go ahead in an aggressive way.”
The company offers a diverse mix of niche veterinary and human APIs, animal feed ingredients, and therapeutic reagents; serving ‘more than 300 customers’ across the animal & human healthcare value chain including the ‘multinational pharma companies, dairy and poultry industry, and small domestic formulators & traders’.
Oxyclozanide was one of key products that was going to be launched and it did not get launched to due impact of floods in the region. The company is all set to restart the launch activities of this product, which will boost it overall topline. Company has a huge asset base with Huge land bank for future expansion. Company’s 100% of business is out of its Own 8 Patented products.
Lasa Supergenerics is a globally well trusted brand with high quality products, accepted by large companies across the globe. The company is the pioneer and amongst the leading players in the manufacturing of Veterinary APIs. It specialises in ‘catalyst chemistry’ and manufactures anthelmintic/ veterinary API products with the largest production capabilities and product categories in India. The company has over 25% of APIs exported to counties like Australia, Bangladesh, Middle East, China, Turkey, Egypt, Jordan, Korea,